Corneal ParametersNCT07629232
Measuring Corneal Parameters
A study testing Investigational device and Comparator device in people with Corneal Parameters, run by Icare Finland Oy at 1 site in Germany.
Trial summary
The aim of this clinical investigation is to assess the feasibility of the investigational device for measuring corneal parameters of the human eye. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Corneal Parameters
- What is being tested?
- Investigational device and Comparator device
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteGermany
- Study dates
- 1 Jun 2026to 30 Sep 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 1. Age ≥ 18 years
Who cannot join
- Subjects with only one functional eye
- Subjects having poor or eccentric fixation in the study eye(s)
- Central corneal scarring (that might affect the measurement result)
- Microphthalmos
- Buphthalmos
- Contact lens use (12 hours prior to measurements)
Show all 10Show fewer
- Severe dry eyes
- Lid squeezers - blepharospasm
- Nystagmus
- Any other corneal or conjunctival pathology or condition that prevents CCT measurements
Trial locations and contacts
1 site in 1 country.
Germany1 site
Universitäts-Augenklinik Bonn
Bonn, North Rhine-Westphalia, 53127
About this study
Official title: Feasibility Study - Measuring Corneal Parameters
The aim of this clinical investigation is to assess the feasibility of the investigational device for measuring corneal parameters of the human eye.
- Conditions
- Corneal Parameters
- Being tested
- Investigational device, Comparator device
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Investigational deviceDevice
Measurement of corneal parameters
Comparator deviceDevice
Measurement of corneal parameters
| Study group | Role | What they receive |
|---|---|---|
| Measurement with the investigational device | Experimental | Not described Receives: Device: Investigational device |
| Measurement with Zeiss IOL Master 700 | Experimental | Not described Receives: Device: Comparator device |
| Measurement with Heidelberg Anterion | Experimental | Not described Receives: Device: Comparator device |
| Measurement with Nidek NT-530P | Experimental | Not described Receives: Device: Comparator device |
What is being measured
The primary outcome is the main question the study is designed to answer.
The primary objective of this study is to collect a comprehensive dataset of central corneal thickness (CCT) values to assess the performance of investigational device.
Measured: Through study completion, an average of 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jun 2026
- Study start1 Jun 2026
- Primary completion30 Sep 2026
- Study completion30 Sep 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Corneal ParametersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Device feasibility
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Icare Finland Oy
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07629232
- Sponsor's protocol ID
- TA05-001
- Status last verified
- Oct 2026
- First submitted
- 22 May 2026
- Last updated
- 20 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility Study - Measuring Corneal Parameters
- ClinicalTrials.gov ID
- NCT07629232
- Acronym / sponsor ID
- TA05-001
- Conditions
- Corneal Parameters
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Icare Finland OyIndustry (pharma, biotech, devices)
- Study start
- 1 Jun 2026 (actual)
- Primary completion
- 30 Sep 2026 (actual)
- Study completion
- 30 Sep 2026 (actual)
- First posted
- 5 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this clinical investigation is to assess the feasibility of the investigational device for measuring corneal parameters of the human eye.
Study design
- Primary purpose
- Device feasibility
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Measurement with the investigational device | Experimental | Device: Investigational device |
| Measurement with Zeiss IOL Master 700 | Experimental | Device: Comparator device |
| Measurement with Heidelberg Anterion | Experimental | Device: Comparator device |
| Measurement with Nidek NT-530P | Experimental | Device: Comparator device |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- 1. Age ≥ 18 years
Key exclusion criteria (10 listed)
- Subjects with only one functional eye
- Subjects having poor or eccentric fixation in the study eye(s)
- Central corneal scarring (that might affect the measurement result)
- Microphthalmos
- Buphthalmos
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Investigational deviceMeasurement of corneal parameters | Device | Measurement with the investigational device |
| Comparator deviceMeasurement of corneal parameters | Device | Measurement with Heidelberg Anterion, Measurement with Nidek NT-530P, Measurement with Zeiss IOL Master 700 |
Primary outcome
The primary objective of this study is to collect a comprehensive dataset of central corneal thickness (CCT) values to assess the performance of investigational device.
Time frame: Through study completion, an average of 2 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Corneal Parameters
RecruitingObservational study
Corneal Biomechanics, Optical Properties and Anterior Segment Structural Features in Patients With Pseudoexfoliation
Pseudoexfoliation Syndrome, Biomechanical Parameters
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Investigational device and Comparator device in people with Corneal Parameters, run by Icare Finland Oy at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The primary objective of this study is to collect a comprehensive dataset of central corneal thickness (CCT) values to assess the performance of investigational device. (time frame: Through study completion, an average of 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026; AzTrials last refreshed its copy on 5 Nov 2026.